FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely aciclovir 30 milligram/1 gram conventional release eye ointment VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cisatracurium besilate 10mg/5ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Waymade Healthcare Plc) 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aciclovir 3% eye ointment (Agepha Pharma s.r.o.) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Necessity Supplies Ltd) 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (GlaxoSmithKline) 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Doncaster Pharmaceuticals Ltd) 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (PI) (Dowelhurst Ltd) 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aciclovir 3% eye ointment 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cisatracurium besilate 10mg/5ml solution for injection ampoules (AS Kalceks) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Dawa Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nimbex 10mg/5ml solution for injection ampoules (GlaxoSmithKline) 5 ampoule 5 x 5ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Dawa Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Sigma Pharmaceuticals Plc) 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Necessity Supplies Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Dawa Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cisatracurium besilate 10mg/5ml solution for injection ampoules 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Lexon (UK) Ltd) 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aciclovir 3% eye ointment (Agepha Pharma s.r.o.) 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Lexon (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (PI) (Dowelhurst Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Mawdsley-Brooks & Company Ltd) 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zovirax 3% ophthalmic ointment (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (Alliance Healthcare (Distribution) Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cisatracurium besilate 10mg/5ml solution for injection ampoules (AS Kalceks) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nimbex 10mg/5ml solution for injection ampoules (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (A A H Pharmaceuticals Ltd) 120 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (A A H Pharmaceuticals Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nicotine 1.5mg lozenges sugar free 100 lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
NiQuitin Minis Mint 1.5mg lozenges (Omega Pharma Ltd) 100 lozenge 5 x 20 lozenges VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Antithrombin III 1,000unit powder and solvent for solution for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Deoxycholic acid 20mg/2ml solution for injection vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) 4 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Belkyra 20mg/2ml solution for injection vials (Allergan Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Deoxycholic acid 20mg/2ml solution for injection vials 4 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zinc oxide powder VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Neuropathy sweat detection pads VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Neuropad neuropathy sweat detection pad (Ark Therapeutics Ltd) 2 pad VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 0.3% eye ointment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phenylephrine 12.2mg capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 8mg / Amlodipine 5mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely metoclopramide hydrochloride 5 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 5cm x 7.5cm VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 7.5cm x 10cm VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing with polyurethane foam film backing sterile and silicone adhesive border 15cm x 20cm VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alginate dressing sterile 15cm x 15cm VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 10cm x 18cm VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Ultrasun Sports gel SPF 50 VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Qlaira tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Ultrasun Sports gel SPF 30 VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ultrasun Sports gel SPF 30 (Ultrasun UK Ltd) 400 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metoclopramide 5mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Maxolon 5mg tablets (Shire Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metoclopramide 5mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metoclopramide 5mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metoclopramide 5mg tablets 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Maxolon 5mg tablets (Shire Pharmaceuticals Ltd) 84 tablet 4 x 21 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ultrasun Sports gel SPF 50 (Ultrasun UK Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Ultrasun Sports gel SPF 30 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Qlaira tablets 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Ultrasun Sports gel SPF 50 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ultrasun Sports gel SPF 30 (Ultrasun UK Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Silicnet dressing 5cm x 7.5cm (Zelador Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Silicnet dressing 5cm x 7.5cm (Zelador Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Silicnet dressing 7.5cm x 10cm (Zelador Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Silicnet dressing 7.5cm x 10cm (Zelador Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Medihealth (Northern) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Silicnet dressing 5cm x 7.5cm (Zelador Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules (Medihealth (Northern) Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Silicnet dressing 7.5cm x 10cm (Zelador Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Zentiva Pharma UK Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (DE Pharmaceuticals) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals) 120 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mebeverine 50mg/5ml oral suspension sugar free (DE Pharmaceuticals) 300 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nifedipine 5mg capsules (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levomepromazine 6mg tablets (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets tropical (Nestle Clinical Nutrition) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mebeverine 50mg/5ml oral suspension sugar free (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets citrus (Nestle Clinical Nutrition) 5 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets tropical (Nestle Clinical Nutrition) 5 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (DE Pharmaceuticals) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets (Flavour Not Specified) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets citrus (Waymade Healthcare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets coffee (Nestle Clinical Nutrition) 5 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets (Waymade Healthcare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets 5 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets (Waymade Healthcare Plc) 5 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets coffee (Nestle Clinical Nutrition) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets citrus (Nestle Clinical Nutrition) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets citrus (Waymade Healthcare Plc) 5 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nifedipine 5mg capsules (DE Pharmaceuticals) 90 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levomepromazine 6mg tablets (DE Pharmaceuticals) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Page 1 of 86 Next End

This concept is not in any reference sets

Back to Start